Barclays on Thursday downgraded the contract research organizations IQVIA Holdings (NYSE:IQV), ICON PLC (NASDAQ:ICLR), and Fortrea Holdings (NASDAQ:FTRE), arguing that the Trump administration’s ...

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments ...

BofA lowered the firm’s price target on Iqvia (IQV) to $190 from $235 and keeps a Buy rating on the shares. Sentiment for Life Sciences and ...

IQVIA’s new technologies are changing clinical trials, reducing the administrative burden on staff and improving insights for sponsors. Greg Lever, Director within the IQVIA Applied Data Science ...

Stifel lowered the firm’s price target on Iqvia (IQV) to $211 from $261 and keeps a Buy rating on the shares. President Trump has discussed ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life ...

Barclays on Thursday downgraded the contract research organizations IQVIA Holdings (NYSE:IQV), ICON PLC (NASDAQ:ICLR), and Fortrea Holdings (NASDAQ:FTRE), arguing that the Trump administration’s ...

IQVIA Holdings Inc. provides clinical research ... It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sciences industries, has been named to the ...